Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDImproving Pain Management During Intrauterine Device Insertion

🎓 Expert Commentary / Peer Perspective
CDC and ACOG guidance call for person-centered, shared decision-making around IUD placement pain. Expert commentary aligned with this guidance identifies paracervical block as the only intervention with consistent evidence of clinical benefit, particularly in vaginally nulliparous patients.


Clinical Considerations

  • Paracervical block repeatedly reduces pain and improves satisfaction in vaginally nulliparous patients, regardless of IUD type
  • NSAIDs and misoprostol show no clinically meaningful pain reduction across multiple double-blind, placebo-controlled trials
  • Nitrous oxide showed no benefit in a prospective randomized trial for IUD placement pain
  • Anxiolytics address procedural anxiety but do not reduce insertion pain — patients should be counseled on this distinction

Practice Applications

  • Integrate proactive pain conversations into every IUD counseling visit
  • Consider paracervical block as the default offer for nulliparous patients
  • Avoid routine pre-procedure NSAIDs or misoprostol for pain prevention
  • Recognize ultrasound guidance may shorten procedure time and aid patient distraction

Related Reading

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form